PVIVAX
Knowledge sharing for relapsing malaria
PVIVAX Knowledge sharing for relapsing malaria
Search
Search
English
\n
Español
\n
Toggle main menu visibility
P. vivax malaria
Malaria and P. vivax malaria
Symptoms & severity
Illness and mortality
Populations at risk
Pregnant women and children
Migratory populations
Role in malaria elimination
Lifecycle
Relapses
Vectors
Diagnosis & treatment
Diagnostic methods
Microscopy
Rapid diagnostic tests
Molecular methods & serology
Diagnosing severe vivax malaria
Treatment
Radical cure
Blood stage treatment
Liver stage treatment
G6PD Deficiency
G6PD Global Prevalence
G6PD diagnostics
Types of G6PD clinical diagnostic tests
Regions & countries
Africa
Ethiopia
Eastern Mediterranean
South East Asia
India
Myanmar
Nepal
Thailand
The Americas
Brazil
Colombia
Peru
Western Pacific
Cambodia
Lao People's Democratic Republic
Viet Nam
Projects
The Partnership for Vivax Elimination (PAVE)
PAVE Latin America
PAVE feasibility studies
PAVE Peru Feasibility Study
First Patient, First Visit (FPFV) in Peru, August 2023
The Tafenoquine Roll-out STudy (TRuST)
O estudo TRuST
SCOPE in Indonesia & PNG
SCOPE Indonesia
SCOPE Papua New Guinea
The ARCTIC Study
Malaria Atlas Project (MAP)
Tools & training
Study database
PAVE Pilot Educational Program (PEP) Toolbox
PAVE Training materials
Cost-effectiveness tool for G6PD RDTs
Resources
Autoimmune Hemolytic Anemia in Plasmodium vivax Malaria.
News & events
Past events
Stories and Videos
About us
Home
Resources
Autoimmune Hemolytic Anemia in Plasmodium vivax Malaria.
Autoimmune Hemolytic Anemia in Plasmodium vivax Malaria.
01 Jun 2017
Ghosh A, Sharma S, Choudhury J